20.85
-0.01
(-0.05%)
At close: April 15 at 4:00:02 PM EDT
20.84
-0.01
(-0.05%)
Pre-Market: 4:09:46 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 0.32 | 0.38 | 1.33 | 1.57 |
| Low Estimate | 0.3 | 0.34 | 1.3 | 1.47 |
| High Estimate | 0.34 | 0.41 | 1.44 | 1.68 |
| Year Ago EPS | -- | -- | 1.47 | 1.33 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 496.06M | 534.25M | 2.1B | 2.24B |
| Low Estimate | 481M | 525.8M | 2.1B | 2.22B |
| High Estimate | 509.1M | 540M | 2.12B | 2.28B |
| Year Ago Sales | -- | -- | 1.9B | 2.1B |
| Sales Growth (year/est) | -- | -- | 10.74% | 6.66% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 |
|---|---|---|
| EPS Est. | 0.36 | 0.17 |
| EPS Actual | 0.37 | 0.17 |
| Difference | 0.01 | 0 |
| Surprise % | 4.10% | 0.38% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.32 | 0.38 | 1.33 | 1.57 |
| 7 Days Ago | 0.32 | 0.38 | 1.33 | 1.57 |
| 30 Days Ago | 0.3 | 0.37 | 1.3 | 1.55 |
| 60 Days Ago | 0.3 | 0.35 | 1.31 | 1.52 |
| 90 Days Ago | 0.3 | 0.36 | 1.3 | 1.52 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 1 |
| Up Last 30 Days | 2 | 4 | 5 | 4 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | 2 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CON | -- | -- | -9.66% | 17.96% |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 3/19/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/12/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/23/2025 |
| Maintains | B of A Securities: Buy to Buy | 1/23/2025 |
| Upgrade | B of A Securities: Neutral to Buy | 12/16/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 11/4/2024 |
Related Tickers
SEM Select Medical Holdings Corporation
16.30
-2.04%
ARDT Ardent Health Partners, Inc.
12.30
-0.97%
PNTG The Pennant Group, Inc.
26.00
-0.12%
SGRY Surgery Partners, Inc.
21.07
-1.17%
LFST LifeStance Health Group, Inc.
6.82
-0.44%
GRDN Guardian Pharmacy Services, Inc.
23.32
+1.88%
MD Pediatrix Medical Group, Inc.
13.34
-0.52%
EHAB Enhabit, Inc.
7.79
0.00%
AUNA Auna SA
6.91
-4.16%
HCSG Healthcare Services Group, Inc.
9.65
-1.43%